Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
10.08
+0.65 (6.89%)
At close: Oct 8, 2025, 4:00 PM EDT
10.15
+0.07 (0.69%)
After-hours: Oct 8, 2025, 7:58 PM EDT
Kura Oncology Market Cap
Kura Oncology has a market cap or net worth of $874.92 million as of October 8, 2025. Its market cap has decreased by -43.51% in one year.
Market Cap
874.92M
Enterprise Value
263.66M
1-Year Change
-43.51%
Ranking
Category
Stock Price
$10.08
Market Cap Chart
Since November 5, 2015, Kura Oncology's market cap has increased from $113.70M to $874.92M, an increase of 669.49%. That is a compound annual growth rate of 22.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2025 | 874.90M | 29.17% |
| Dec 31, 2024 | 677.30M | -36.58% |
| Dec 29, 2023 | 1.07B | 28.64% |
| Dec 30, 2022 | 830.20M | -10.90% |
| Dec 31, 2021 | 931.80M | -49.69% |
| Dec 31, 2020 | 1.85B | 197.24% |
| Dec 31, 2019 | 623.10M | 16.69% |
| Dec 31, 2018 | 534.00M | 15.51% |
| Dec 29, 2017 | 462.30M | 266.61% |
| Dec 30, 2016 | 126.10M | -29.75% |
| Dec 31, 2015 | 179.50M | 57.87% |
| Nov 5, 2015 | 113.70M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 759.23B |
| Johnson & Johnson | 456.84B |
| AbbVie | 408.50B |
| UnitedHealth Group | 335.03B |
| AstraZeneca | 266.28B |
| Novo Nordisk | 265.74B |
| Novartis AG | 257.26B |
| Abbott Laboratories | 233.69B |